The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVerici Dx Regulatory News (VRCI)

Share Price Information for Verici Dx (VRCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.75
Bid: 7.50
Ask: 8.00
Change: 0.00 (0.00%)
Spread: 0.50 (6.667%)
Open: 7.75
High: 7.75
Low: 7.75
Prev. Close: 7.75
VRCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

13 Apr 2021 14:06

RNS Number : 3377V
Verici Dx PLC
13 April 2021
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMUORORANUSAAR

Date   Source Headline
27th Feb 20244:08 pmRNSHolding(s) in Company
22nd Feb 20247:00 amRNSHolding(s) in Company
21st Feb 20244:53 pmRNSHolding(s) in Company
21st Feb 20247:00 amRNSHolding(s) in Company
19th Feb 202412:35 pmRNSResult of General Meeting
14th Feb 20247:00 amRNSResult of Retail Offer
31st Jan 20247:00 amRNSVerici Dx announces new research initiative
26th Jan 202412:32 pmRNSPublication of Circular
25th Jan 202411:00 amRNSLaunch of Retail Offer
24th Jan 20246:11 pmRNSResult of Placing
24th Jan 202410:39 amRNSClose of Accelerated Bookbuild
24th Jan 20247:00 amRNSProposed Fundraising
8th Jan 20247:00 amRNSMedicare National Payment Rate Confirmation
8th Jan 20247:00 amRNSCAP accreditation
11th Dec 20237:00 amRNSTutiviaâ„¢ validation study published in Journal
29th Nov 20237:00 amRNSISO 27001 Information Security Certification
20th Nov 20237:00 amRNSInvestor Presentation
15th Nov 20237:00 amRNSCommercialisation agreement with Thermo Fisher
2nd Nov 20237:00 amRNSClaravaâ„¢ poster to be presented at ASN Kidney Week
29th Sep 20237:00 amRNSHalf-year Report
20th Jul 20237:00 amRNSCLIA Certificate of Compliance update
6th Jul 20237:00 amRNSInvestor Presentation
3rd Jul 20237:00 amRNSSuccessful clinical validation of Clarava™
29th Jun 20234:57 pmRNSResult of AGM
6th Jun 20237:00 amRNSNotice of AGM and posting of Annual Report
5th Jun 20237:01 amRNS2022 Annual Results
5th Jun 20237:00 amRNSProposed US pricing for Tutivia™
31st May 20237:00 amRNSNotice of Results
24th May 20237:01 amRNSUpdate re. EKF distribution of shares in Verici Dx
24th May 20237:00 amRNSDistribution of shares in Verici Dx plc
24th Apr 20237:00 amRNSFinal results timing
28th Mar 202311:05 amRNSSecond Price Monitoring Extn
28th Mar 202311:00 amRNSPrice Monitoring Extension
28th Mar 20239:05 amRNSSecond Price Monitoring Extn
28th Mar 20239:00 amRNSPrice Monitoring Extension
27th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 202311:05 amRNSSecond Price Monitoring Extn
27th Mar 202311:00 amRNSPrice Monitoring Extension
22nd Mar 20237:00 amRNSOperational Update
21st Mar 20234:40 pmRNSSecond Price Monitoring Extn
21st Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20237:00 amRNSStatement re. Silicon Valley Bank
9th Mar 20237:00 amRNSTwo key patents granted in the US
2nd Mar 20237:00 amRNSCLIA Certificate of Compliance
27th Feb 20232:00 pmRNSPrice Monitoring Extension
7th Dec 20227:00 amRNSDirector/PDMR Shareholding
1st Dec 20226:07 pmRNSCorrection: Holding(s) in Company
3rd Oct 20227:00 amRNSProduct rebranding as Tutivia™
7th Sep 20227:00 amRNSHalf-year Report
6th Sep 20227:00 amRNSPositive results for Clarava from validation study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.